RESUMEN
The study was carried out on a material obtained by a biopsy from 18 children having different types of hemangiomas (capillary, cavernous and combined). Histochemical reactions were applied for the following enzymes: Succenatedehydrogenase (SDH), lactatdehydrogenase (LDH), cytochromoxidase, acid phosphatase, alkaline phosphatase and paraspecific esterases. Differently reduced activity of the succenatedehydrogenase and the cytochromoxidase in the endothelial cells and the pericytes was established. A reduced enzyme activity was observed also in a large part of the cases of acid phosphatase. The activity of the alkaline phosphatase and paraspecific esterases was greatly increased. Based on their observations the authors relate the hemangiomas to the tumour formations with a good prognosis.
Asunto(s)
Hemangioma Capilar/enzimología , Hemangioma Cavernoso/enzimología , Histocitoquímica/métodos , Neoplasias de Tejido Vascular/enzimología , Fosfatasa Ácida/metabolismo , Fosfatasa Alcalina/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Endotelio Vascular/enzimología , Endotelio Vascular/patología , Esterasas/metabolismo , Femenino , Hemangioma Capilar/patología , Hemangioma Cavernoso/patología , Humanos , Lactante , L-Lactato Deshidrogenasa/metabolismo , Masculino , Neoplasias de Tejido Vascular/patología , Succinato Deshidrogenasa/metabolismoRESUMEN
Canine hemangiosarcoma (HSA) is an endothelial cell malignancy driven, in part, by activating mutations in receptor and non-receptor tyrosine kinases. Proteomics, Western blots and a tyrosine kinase inhibitor were used to elucidate activating mechanisms in HSA cell lines. Phosphotyrosine peptides from focal adhesion kinase (FAK) STAT3, Lyn, Fyn and other signal transduction kinases were identified by mass spectrometry. FAK was constitutively activated at tyrosine 397, the autophosphorylation site, and this was reversible with high concentrations of a FAK inhibitor. FAK inhibitor-14 suppressed migration and phosphorylation of FAK tyrosine 397 and tyrosines 576/577 and was cytotoxic to HSA cells suggesting FAK signalling may be an important contributor to canine HSA survival.
Asunto(s)
Enfermedades de los Perros/enzimología , Proteína-Tirosina Quinasas de Adhesión Focal/metabolismo , Hemangiosarcoma/veterinaria , Neoplasias de Tejido Vascular/veterinaria , Fosfotirosina/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Animales , Western Blotting/veterinaria , Línea Celular Tumoral , Enfermedades de los Perros/tratamiento farmacológico , Perros , Proteína-Tirosina Quinasas de Adhesión Focal/antagonistas & inhibidores , Hemangiosarcoma/tratamiento farmacológico , Hemangiosarcoma/enzimología , Espectrometría de Masas/veterinaria , Neoplasias de Tejido Vascular/tratamiento farmacológico , Neoplasias de Tejido Vascular/enzimología , Proteómica/métodos , Proteínas Proto-Oncogénicas c-fyn/efectos de los fármacos , Proteínas Proto-Oncogénicas c-fyn/metabolismo , Factor de Transcripción STAT3/efectos de los fármacos , Factor de Transcripción STAT3/metabolismo , Transducción de Señal/efectos de los fármacos , Familia-src Quinasas/efectos de los fármacos , Familia-src Quinasas/metabolismoRESUMEN
BACKGROUND: Tumors of endothelium range from benign hemangiomas of infancy to highly malignant angiosarcomas of the elderly. Hemangiomas are the most common tumors in infants and may affect up to 10% of all children. The biologic behavior of these lesions ranges from self-resolving, in the case of hemangiomas and pyogenic granulomas, to lethal metastatic neoplasms in the case of angiosarcoma. Although the clinical outcomes of these diseases are easily distinguished, the biologic basis for these differences is not well understood. Activation of mitogen-activated protein kinase (MAPK) is an important signal transduction mechanism that may predict response of a tumor to chemotherapy. OBJECTIVE: Our purpose was to examine expression of phosphorylated (activated) MAPK in hemangiomas of infancy, pyogenic granulomas, hemangioendotheliomas, and angiosarcomas to determine whether phosphorylated MAPK was expressed in endothelial tumors. In addition, we examined endothelial tumors of infectious origin, Kaposi's sarcoma, and verruga peruana. METHODS: Skin sections from benign and malignant endothelial tumors, including hemangioma of infancy, angiosarcoma, and infectious endothelial lesions (Kaposi's sarcoma, verruga peruana) were stained with an antibody specific for phosphorylated MAPK. RESULTS: We demonstrated strong expression of phosphorylated MAPK in benign endothelial tumors, including capillary hemangioma of infancy and pyogenic granuloma, and greatly decreased expression in angiosarcoma. In addition, infectious endothelial tumors stained strongly with this antibody, similar to benign tumors. The presence of immunoreactive phosphorylated MAPK appears to be inversely correlated with degree of malignancy. CONCLUSION: We demonstrate that the use of antibodies specific for signal transduction pathways is feasible in paraffin-fixed tissue. Thus the activity of a given signal transduction pathway can be ascertained in a biopsy specimen. Immunohistochemistry for phosphorylated MAPK may help the pathologist distinguish benign from malignant endothelial processes and thus guide therapy.